|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2003-6-25
|
|
pubmed:abstractText |
It is not clear whether pathological changes following neoadjuvant hormonal therapy (NHT) prior to radical prostatectomy have any value as predictors of progression in prostate cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0919-8172
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
377-82
|
|
pubmed:dateRevised |
2006-10-30
|
|
pubmed:meshHeading |
pubmed-meshheading:12823692-Aged,
pubmed-meshheading:12823692-Aged, 80 and over,
pubmed-meshheading:12823692-Androgen Antagonists,
pubmed-meshheading:12823692-Chemotherapy, Adjuvant,
pubmed-meshheading:12823692-Disease Progression,
pubmed-meshheading:12823692-Follow-Up Studies,
pubmed-meshheading:12823692-Humans,
pubmed-meshheading:12823692-Male,
pubmed-meshheading:12823692-Middle Aged,
pubmed-meshheading:12823692-Prostate,
pubmed-meshheading:12823692-Prostate-Specific Antigen,
pubmed-meshheading:12823692-Prostatectomy,
pubmed-meshheading:12823692-Prostatic Neoplasms,
pubmed-meshheading:12823692-Recurrence,
pubmed-meshheading:12823692-Retrospective Studies,
pubmed-meshheading:12823692-Risk Assessment
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Pathological effects of neoadjuvant hormonal therapy help predict progression of prostate cancer after radical prostatectomy.
|
|
pubmed:affiliation |
Department of Urology, National Kanazawa Hospital, Kanazawa, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
